Influence of NASCET/ACAS trial eligibility on outcome after carotid endarterectomy.

@article{Lepore2001InfluenceON,
  title={Influence of NASCET/ACAS trial eligibility on outcome after carotid endarterectomy.},
  author={Michael R Lepore and W. Charles Sternbergh and K Salartash and Britt H Tonnessen and Samuel R. Money},
  journal={Journal of vascular surgery},
  year={2001},
  volume={34 4},
  pages={581-6}
}
PURPOSE Proponents of carotid angioplasty and stenting suggest that "high risk" patients, defined as patients excluded from the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and Asymptomatic Carotid Atherosclerosis Study (ACAS), may have a significantly higher risk of stroke with carotid endarterectomy (CEA). However, this selected patient cohort has been poorly studied. METHODS A retrospective review of patients who underwent CEA during a 2-year period at a tertiary… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Proponents of carotid angioplasty and stenting suggest that " high risk " patients , defined as patients excluded from the North American Symptomatic Carotid Endarterectomy Trial ( NASCET ) and Asymptomatic Carotid Atherosclerosis Study ( ACAS ) , may have a significantly higher risk of stroke with carotid endarterectomy ( CEA ) .
Proponents of carotid angioplasty and stenting suggest that " high risk " patients , defined as patients excluded from the North American Symptomatic Carotid Endarterectomy Trial ( NASCET ) and Asymptomatic Carotid Atherosclerosis Study ( ACAS ) , may have a significantly higher risk of stroke with carotid endarterectomy ( CEA ) .
Proponents of carotid angioplasty and stenting suggest that " high risk " patients , defined as patients excluded from the North American Symptomatic Carotid Endarterectomy Trial ( NASCET ) and Asymptomatic Carotid Atherosclerosis Study ( ACAS ) , may have a significantly higher risk of stroke with carotid endarterectomy ( CEA ) .
Proponents of carotid angioplasty and stenting suggest that " high risk " patients , defined as patients excluded from the North American Symptomatic Carotid Endarterectomy Trial ( NASCET ) and Asymptomatic Carotid Atherosclerosis Study ( ACAS ) , may have a significantly higher risk of stroke with carotid endarterectomy ( CEA ) .
All Topics